ReviewFrontiers in oncology2023

T-cell redirecting therapies for B-cell non-Hodgkin lymphoma: recent progress and future directions.

David A Russler-Germain et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.